María Victoria M. M.
- Country
- Spain
- Department
- Servicio de Hematologia
Research Overview
- A Phase 3b, Multicenter, Open-label, Daratumumab Long-term Extension Study
- Phase III Randomized Open‑Label Study of Cevostamab Combination Therapy Versus Standard of Care in Relapsed/Refractory Multiple Myeloma After 1‑3 Prior Lines
- Phase II Multicenter Study of Belantamab Mafodotin with VRd in Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 61 of 177 partner sites.
Specializations
Acute Myeloid Leukemia & Myelodysplastic Syndromes
Focus on high‑risk Acute Myeloid Leukemia and related Myelodysplastic Syndromes in adult patients.
- Relapsed or refractory AML
- NPM1‑mutated AML
- High‑risk MDS
- Ring sideroblast anemia
- TP53‑mutated disease
Investigates molecular drivers and therapeutic resistance.
B‑Cell and T‑Cell Lymphoid Malignancies
Research on diverse Non‑Hodgkin Lymphoma subtypes and rare T‑cell lymphomas.
- Diffuse large B‑cell lymphoma
- Mantle cell lymphoma
- Follicular lymphoma
- Peripheral T‑cell lymphoma
- Richter transformation
Emphasis on targeted agents and immunotherapy.
Systemic Amyloidosis
Dedicated to plasma‑cell derived AL Amyloidosis and transthyretin‑related ATTR Amyloidosis with cardiac involvement.
- Mayo stage IV AL
- Cardiac ATTR
- Renal amyloid
- Amyloid burden reduction
- Quality‑of‑life outcomes
Integrates biomarkers for disease monitoring.
Hematopoietic Stem Cell Transplantation & Graft‑versus‑Host Disease
Specializes in allogeneic transplantation complications, including Graft‑versus‑Host Disease and transplant‑associated microangiopathy.
- Acute GVHD of gut
- Chronic GVHD
- Transplant‑associated thrombotic microangiopathy
- Immune reconstitution
- Prophylactic strategies
Aims to improve survival post‑transplant.
Hematologic‑Related Cardiovascular and Anemia Disorders
Explores cardiovascular sequelae of hematologic disease and management of chronic Anemia.
- Iron‑deficiency anemia in MDS
- Cardiac amyloid cardiomyopathy
- Thromboembolic risk in myeloproliferative neoplasms
- Heart failure with reduced ejection fraction
- Platelet dysfunction
Links hematologic pathology with organ‑specific outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.